Picture of Bicycle Therapeutics logo

BCYC Bicycle Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Bicycle Therapeutics PLC reports results for the quarter ended in September 30 - Earnings Summary

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of 74 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-1.26.  The mean expectation of
thirteen analysts for the quarter was for a loss of 78 cents per
share. Wall Street expected results to range from $-1.05 to -54
cents per share.
    * Revenue fell 50% to $2.68 million from a year ago;
analysts
expected $6.84 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of 74 cents​.
    * The company reported a quarterly loss of $50.8 million.
    * Bicycle Therapeutics PLC shares had risen by 6.2% this
quarter and gained 32.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 33.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is 38.00 
This summary was machine generated from LSEG data November 1 at
03:42 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.78          -0.74          Beat
 Jun. 30 2024      -1.10          -0.77          Beat
 Mar. 31 2024      -1.24          -0.62          Beat
 Dec. 31 2023      -1.23          -1.16          Beat

Recent news on Bicycle Therapeutics

See all news